Backs FY25 revenue view up 5%-8%, consensus $1.4B. Backs FY25 free cash flow view $130M-$180M.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HAE:
- Haemonetics 1st Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website
- HAE Earnings this Week: How Will it Perform?
- TipRanks’ ‘Perfect 10’ List: Analysts Pound the Table on These 2 Top-Scoring Stocks
- Haemonetics gets CE Mark for SavvyWire Pre-Shaped Pressure Guidewire
- AMD initiated, Paramount downgraded: Wall Street’s top analyst calls